-
JC-1 Mitochondrial Membrane Potential Assay Kit Guide
2026-08-24
Learn how the JC-1 Mitochondrial Membrane Potential Assay Kit, SKU K2002, can clarify apoptosis and mitochondrial function when conventional viability data are difficult to interpret. This scenario-based guide covers assay principles, sample compatibility, protocol controls, data analysis, and practical vendor-selection criteria.
-
Demethyleneberberine in Neurodegeneration: Review
2026-08-23
The 2022 Molecular Biology Reports review presents Demethyleneberberine (DMB), a berberine metabolite, as a mechanistically plausible candidate for neurodegenerative disease research. Its proposed activity centers on reducing neuroinflammation and oxidative stress while modulating NF-κB, MAPK, and AMPK signaling, although direct disease-modifying efficacy remains to be established.
-
Ultrasound-Triggered Peroxynitrite Therapy in Lung Cancer
2026-08-22
A 2026 Chemical Engineering Journal study developed M@DRSZ, a pH-sensitive, A549-membrane-coated ZIF-8 nanoparticle integrating doxorubicin, an NO donor, Rhein, sonodynamic therapy, and tumor homotargeting. Ultrasound activation generated reactive oxygen and nitrogen species, promoted peroxynitrite-associated apoptosis, improved tumor localization, and remodeled antitumor immunity in experimental lung cancer models.
-
Mechanical Stress, Cytoskeleton, and Autophagy
2026-08-22
The reference study provides direct evidence that compression-induced autophagy depends strongly on cytoskeletal microfilaments, while microtubules make a supporting contribution. Its force–time design and combined fluorescence, biochemical, and cytoskeletal perturbation strategy offer a useful framework for studying mechanotransduction without assuming that all cytoskeletal components have equivalent functions.
-
Triiodothyronine T3 Workflows for Adipose Research
2026-08-21
Build more informative adipose experiments with Triiodothyronine (T3), from thyroid hormone receptor activation assays to beige-fat thermogenesis and cellular metabolism measurements. This practical guide combines formulation controls, staged treatment designs, and troubleshooting strategies with the SETD7 browning study to distinguish adipogenesis from thermogenic function.
-
HyperScribe™ Poly (A) Tailing Kit for RNA
2026-08-20
Convert capped in vitro transcripts into more translation-ready RNA with a controlled enzymatic poly(A)-tailing workflow. The HyperScribe™ Poly (A) Tailing Kit is especially useful for transient expression, transfection experiments, micro-injection, and mechanistic studies that require reproducible RNA input.
-
Ultrasound-Activated Nanoparticles for Lung Cancer
2026-08-20
A 2026 Chemical Engineering Journal study developed an A549-membrane-coated, pH-sensitive ZIF-8 nanoparticle that combines doxorubicin, an NO donor, sonodynamic activity, and tumor homotargeting. Ultrasound-triggered ROS, NO, and peroxynitrite production promoted mitochondrial and lysosomal injury, apoptosis, tumor suppression, and immune remodeling in experimental lung cancer models.
-
Targeted mRNA Nanoparticles in Ischemic Stroke
2026-08-19
Gao and colleagues developed mannose-targeted lipid nanoparticles carrying interleukin-10 mRNA to redirect microglia toward a protective phenotype after ischemic stroke. In mouse models, this feedback-based strategy reduced neuroinflammation, improved blood–brain barrier integrity, limited neuronal apoptosis, and alleviated neurological deficits, supporting targeted mRNA delivery as a poststroke repair approach.
-
Lipo3K Transfection Reagent for Ferroptosis Studies
2026-08-19
Lipo3K Transfection Reagent combines efficient DNA, siRNA, and mRNA delivery with a low-toxicity workflow suited to difficult cancer cell models. This practical guide shows how to use it to interrogate the OTUD3–SLC7A11 axis, sunitinib resistance, and ferroptosis while preserving assay quality.
-
EdU Imaging Kits (Cy5) for S-Phase Studies
2026-08-18
EdU Imaging Kits (Cy5) combine click-chemistry DNA labeling with morphology-preserving detection for microscopy and flow cytometry. This practical guide shows how to apply the assay to hypoxia-driven endothelial proliferation, pharmacodynamic testing, and genotoxicity assessment while avoiding common signal and workflow failures.
-
Ciprofloxacin Beyond Antibiotics: Assay Design
2026-08-18
Explore how Ciprofloxacin connects bacterial topoisomerase biology with emerging ultrasound-guided nanotheranostic assays. This article translates a 2026 TNBC study into practical decisions for formulation, controls, readouts, and research interpretation.
-
B7H3×CD3 BiTE mRNA-LNPs in Cancer Therapy
2026-08-17
Huang and colleagues developed an ionizable lipid nanoparticle system for delivering mRNA encoding a B7H3×CD3 bispecific T-cell engager. The study shows how transient, in vivo BiTE production can address manufacturing and pharmacokinetic limitations associated with recombinant antibodies while producing durable antitumor activity in hematologic malignancies and melanoma models.
-
Alternariol (AOH): Applied Research Workflows
2026-08-17
Alternariol (AOH) supports integrated mycotoxin research spanning hepatic stellate-cell activation, apoptosis mechanism research, CYP metabolism, and detoxification screening. This workflow emphasizes controlled dosing, orthogonal phenotyping, and comparison with other Alternaria toxins to distinguish fibrosis-related signaling from nonspecific cytotoxicity.
-
RIPostC, BHBA, and Ferroptosis in Stroke
2026-08-16
A 2024 ACS Chemical Neuroscience study identifies ketone body metabolism as a mechanistic link between remote ischemic postconditioning and neuroprotection after ischemic stroke. In rat and neuronal-cell models, the intervention improved energy status, limited iron-dependent lipid peroxidation, preserved GPX4, and suppressed ACSL4, providing a framework for testing 3-hydroxybutyrate (BHBA) in ischemia-related research.
-
CORE LNPs Shift mRNA Expression Toward the Spleen
2026-08-15
The CORE study introduces cholesterol-altered lipid nanoparticles engineered to redirect intravenously administered mRNA away from the liver and toward the spleen. By combining synthesis of heterocyclic cholesterol derivatives, computational characterization, design-of-experiment optimization, and in vivo testing, the authors identify a strategy for organ-selective mRNA delivery relevant to vaccination and immune modulation.